tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FDMT Stock Latest News

RBC says 4D Molecular ‘oversold’ after ‘right decision’ about Phase 3 pivot
The FlyRBC says 4D Molecular ‘oversold’ after ‘right decision’ about Phase 3 pivot
13h ago
FDMT
4D Molecular falls after wet AMD data is viewed as mixed
PremiumThe Fly
4D Molecular falls after wet AMD data is viewed as mixed
14h ago
FDMT
4D Molecular price target raised to $39 from $38 at Chardan
PremiumThe Fly
4D Molecular price target raised to $39 from $38 at Chardan
19h ago
FDMT
4D Molecular announces data from PRISM, 4FRONT trials
PremiumThe Fly
4D Molecular announces data from PRISM, 4FRONT trials
1d ago
FDMT
4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
PremiumPress Releases
4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
1d ago
FDMT
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe FlyJMP Securities healthcare analysts hold an analyst/industry conference call
6d ago
OPT
ABBV
4DMT to Participate in the 2024 Cantor Global Healthcare Conference
Premium
Press Releases
4DMT to Participate in the 2024 Cantor Global Healthcare Conference
17d ago
FDMT
4D Molecular to host 4D-150 Wet AMD Development Day
Premium
The Fly
4D Molecular to host 4D-150 Wet AMD Development Day
24d ago
FDMT
4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
PremiumPress Releases
4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
1M ago
FDMT
4D Molecular strengthens management team with appointments
PremiumThe Fly
4D Molecular strengthens management team with appointments
2M ago
FDMT
4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory Board
PremiumPress Releases
4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory Board
2M ago
FDMT
4D Molecular Therapeutics to Present PRISM Trial Interim Data
PremiumCompany Announcements
4D Molecular Therapeutics to Present PRISM Trial Interim Data
2M ago
8K
FDMT
Chardan maintains odds of success assumptions for 4D Molecular after data
PremiumThe FlyChardan maintains odds of success assumptions for 4D Molecular after data
2M ago
FDMT
RBC thinks 4D-150 continues to look ‘best-in-class’ despite ‘safety blip’
Premium
The Fly
RBC thinks 4D-150 continues to look ‘best-in-class’ despite ‘safety blip’
2M ago
FDMT
4D Molecular price target lowered to $40 from $63 at BMO Capital
Premium
The Fly
4D Molecular price target lowered to $40 from $63 at BMO Capital
2M ago
ADVM
FDMT
4D Molecular to hold a conference call
PremiumThe Fly
4D Molecular to hold a conference call
2M ago
FDMT
4D Molecular announces interim data from PRISM trial
PremiumThe Fly
4D Molecular announces interim data from PRISM trial
2M ago
FDMT
4DMT Announces Positive Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Population Affirming Favorable Safety Profile and Robust Clinical Activity
PremiumPress Releases
4DMT Announces Positive Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Population Affirming Favorable Safety Profile and Robust Clinical Activity
2M ago
FDMT
FDA clears 4D Molecular’s IND Application for 4D-175 for GA treatment
PremiumThe Fly
FDA clears 4D Molecular’s IND Application for 4D-175 for GA treatment
3M ago
FDMT
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
PremiumPress Releases4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
3M ago
FDMT
4D Molecular presents interim data from Phase 1/2 AEROW trial
Premium
The Fly
4D Molecular presents interim data from Phase 1/2 AEROW trial
4M ago
FDMT
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis Conference
Premium
Press Releases
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Modulator-Ineligible/-Intolerant Cystic Fibrosis at 47th European Cystic Fibrosis Conference
4M ago
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >